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 Introduction
 Argyrophilic grain disease (AgD) is a late-onset tau-
opathy, accounting for approximately 5–13% of neurode-
generative dementias  [1–4] . In a series of old dementia 
patients, AgD was found to be the second most common 
form of degenerative dementia after Alzhei mer’s disease 
(AD)  [2] . AgD is histopathologically characterized by 
abundant spindle-shaped argyrophilic grains (ArG) in 
neuronal processes and coiled bodies in oligodendro-
cytes. ArG consist of hyperphosphorylated and abnor-
mally phosphorylated tau, and are primarily found in 
limbic regions such as the hippocampus, the entorhinal 
and transentorhinal cortices, and the amygdala. Saito et 
al.  [3] proposed the following neuropathological staging 
paradigm: stage I = ArG restricted to the ambient gyrus 
and its vicinity; stage II = ArG more apparent in the an-
terior and posterior medial temporal lobe, including the 
temporal pole, as well as the subiculum and entorhinal 
cortex; stage III = abundant ArG in the septum, insular 
cortex and anterior cingulate gyrus, accompanying 
spongy degeneration of the ambient gyrus. Biochemical 
studies indicate that AgD is a 4-repeat tauopathy similar 
 Key Words
 Argyrophilic grain disease   Dementia   
Autopsy-confirmed   Retrospective Dementia Inventory
 Abstract
 Background/Aims: We aimed at characterizing the clinical 
features of dementia associated with argyrophilic grain dis-
ease (AgD).  Methods: Relatives or close friends of 24 indi-
viduals with autopsy-confirmed AgD and 29 patients with 
autopsy-confirmed Alzheimer’s disease (AD) were adminis-
tered a novel Retrospective Dementia Inventory to assess 
the cognitive, behavioral and affective symptoms of the de-
ceased patients.  Results: AgD patients showed less severe 
impairments in memory, language, attention and executive 
function than AD patients.  Conclusion: Compared to AD pa-
tients, individuals suffering from AgD appear to present with 
comparable deficits in behavior and affect but relatively 
spared cognitive functioning. 
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to progressive supranuclear palsy and corticobasal de-
generation, but distinct from AD and Pick’s disease  [5] . 
A familial form of AgD has not yet been reported, nor 
has a genetic alteration on the tau gene been identified. 
Whereas one study suggests an association of AgD with 
the apolipoprotein E   2 allele, the apolipoprotein E   4 
allele does not appear to be a susceptibility factor in AgD 
 [6] .
 While much progress has been made in deciphering 
the neuropathology and molecular pathology of AgD, 
the clinical characteristics of this disease, particularly 
its cognitive and behavioral features, have scarcely been 
investigated. Mental deterioration and personality 
changes have been reported in a number of AgD cases 
 [1, 7] , and some AgD cases have been reported who pre-
sented with the clinical features of frontotemporal de-
mentia  [8] . The goal of the present study was to deter-
mine whether AgD can be characterized by a distinctive 
clinical pattern in terms of onset and relevance of symp-
toms.
 Methods
 Subjects
 Between 1994 and 2000, 115 cases were neuropathologically 
diagnosed  [9] with AgD at the Department of Neuropathology
of the University Hospital Basel, Switzerland. Sixty-one neuro-
pathologically confirmed  [10] cases with AD (diagnosed between 
1997 and 2000) were available for comparison. The next of kin of 
the deceased patients were contacted by their family physicians 
and invited to participate in the study. The former caregivers of 
24 deceased patients with AgD and of 29 deceased patients with 
AD agreed to participate.  Table 1 shows the demographics of both 
patient and informant groups. The 2 patient groups did not differ 
significantly with respect to gender distribution and duration of 
dementia, but age at death was significantly higher in the AD 
group. The AgD and AD informant groups were comparable with 
respect to age, Mini Mental Status Examination (MMSE) score 
 [11] and type of relationship with the patient, but differed with 
respect to their gender distribution.
 The local ethics committee approved this study and written 
informed consent was obtained from all participants.
 Neuropathology
 All AgD cases were characterized by the presence of abundant 
ArG in limbic areas, including sector CA1 of the hippocampus, 
the prosubiculum, the entorhinal and transentorhinal cortices, 
the parahippocampal cortex, the ambient gyrus and the amygda-
loid complex. In most cases, high densities of ArG were also pres-
ent in the hypothalamic lateral tuberal nucleus. Many coiled bod-
ies were found within the white matter close to cortical areas rich 
in ArG. ArG were sparse in the anterobasal portions of the in-
sula, as well as in the temporopolar and frontoorbital neocortex. 
Mild to moderate AD pathology was found in all AgD cases, con-
sisting of neurofibrillary tangles and neuropil threads. The dis-
tribution of neurofibrillary tangles corresponded to Braak stage I 
in 6 cases (25.0%), Braak stage II in 10 cases (41.7%) and Braak 
stage III in 8 cases (33.3%)  [12] . In 11 cases (44.8%) a few scattered 
senile plaques were found in the hippocampal formation and the 
neocortex, whereas no plaques were detected in 13 cases (55.2%). 
  -Synuclein-stained Lewy bodies were found in the amygdala of 
2 AgD cases (8.3%).
 Among the 29 AD cases, 6 (20.7%) corresponded to Braak 
stage IV, 8 (27.7%) to Braak stage V, and 15 (51.7%) to Braak stage 
VI. All AD cases had a CERAD neuritic plaque score of ‘C’  [13] . 
Lewy bodies were found in the amygdala of 12 AD cases (41.4%).
 Few lacunar infarcts in the basal ganglia and/or the cerebral 
white matter were present in 5 AgD (20.8%) and in 8 AD cases 
(27.7%).
 Table 1. Demographic characteristics of AgD and AD patients and their informants
 AgD  AD  Statistical significance 
 Patients 24 29 
 Gender, women/men  11/13  18/11  NS 
 Age at death, mean years  8 SD 81.8 8 6.0 86.2 8 6.4  t = 2.6; p < 0.02 
 Duration of dementia, mean years  8 SD 5.6 8 4.6 7.4 8 6.4  NS 
 Informants 24 29 
 Gender, women/men 21/3  15/14   2  (2) = 7.71, p < 0.01 
 Age, mean years  8 SD 66.2 8 11.1 63.0 8 12.3  NS 
 Mini Mental Status Examination, mean  8 SD 28.2 8 1.6 28.2 8 1.6  NS 
 Relationship to patient 
 Spouse/partner 8 (33%) 6 (21%)  NS 
 Children, relatives, friends 16 (66%) 23 (79%)  NS 
 NS = Not significant. 
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 Retrospective Dementia Inventory
 Informant interviews were conducted using an extended ver-
sion of the Retro Brief Clinical Rating Scale (RetroBCRS)  [14] , the 
Retrospective Dementia Inventory (RDI). The RetroBCRS has 
proven to be a valid method of retrospectively determining AD in 
autopsy-confirmed patients  [14] . The new RDI was developed to 
assess the deceased patient’s symptoms along 3 axes: (1) activities 
of daily living (ADL)/behavior, (2) affect and (3) cognition  [15] . It 
comprises 140 questions, of which 117 were taken from the Ret-
roBCRS  [14] , 5 from the Clinical Dementia Rating Scale  [16] ,
4 from the Nurses’ Observation Scale for Geriatric Patients  [17] ,
3 from the Neuropsychiatric Inventory  [18] and 11 were newly 
created questions. The symptom or symptoms queried by each 
question were identified and allocated to 1 of the 3 axes. In total, 
42 questions assessed 8 ADL/behavioral symptoms (social behav-
ior, ADL, hobbies, motor behavior, disturbing behavior, conti-
nence, sleep and appetite), 30 questions assessed 9 affective symp-
toms (aggression, depression, lability, disinhibition, mood, anxi-
ety, delusion, hallucinations and compulsion) and 93 questions 
assessed 11 cognitive symptoms (language, face recognition, ob-
ject recognition, recent memory, past memory, attention, concen-
tration, problem solving, judgment, orientation and instrumental 
ADL). Each question asked the informant whether a particular 
aspect of a symptom was present, and if so, its onset (recorded as 
number of years prior to death). The ‘extent’ of each symptom was 
calculated as the percentage of positively answered questions per 
symptom. In addition, ‘symptom load’ was calculated as the prod-
uct of symptom duration (number of years) and extent (percent-
age) to estimate the clinical relevance of each symptom  [18] .
 Procedure
 The examiner (G.M.S.) interviewed all informants at her of-
fice or at the informant’s home. On average, these interviews took 
about 2 h (1–2.5 h). The delay between death and time of interview 
differed between the 2 groups [AgD: 3.7  8 2.3 years vs. AD: 1.7 
 8 0.9 years; t(51) = 4.2, p  ! 0.0001]. After the interview, infor-
mants were administered the MMSE  [11] . The interview material 
from 1 female informant in the AgD group was disregarded since 
she scored less than 24 points on the MMSE.
 Statistics
 Data were analyzed with the Statistical Package for the Social 
Sciences (SPSS, version 10.0). The   2  test, t test and Bonferroni-
Holm test were used as appropriate. Statistical comparisons be-
tween the AgD and AD groups were made for ‘symptom onset’ 
and ‘symptom load’.
 Results
 The rated onsets of each type of ADL/behavioral, af-
fective and cognitive symptom in the AgD and AD pa-
tients are shown in  figure 1 . AgD patients experienced 
difficulties verbalizing and articulating approximately 2 
years later than AD patients (both p  ! 0.02). Moreover, 
AgD patients retained their problem-solving skills on av-
erage 2 years longer than AD patients (p  ! 0.05), and there 
was a trend (p = 0.06) for AgD patients to display prob-
lems in judgment later than AD patients (that is half a 
year vs. 2 years prior to death). The onsets of all other 
symptoms were comparable in the AgD and AD patient 
groups.
 Symptom loads are shown in  figure 2 . The symptom 
loads of several cognitive symptoms were significantly 
lower in the AgD compared to the AD patients: attention 
(p  ! 0.02), language (verbal expression: p  ! 0.02; articula-
tion: p  ! 0.01), memory (recent memory: p  ! 0.01; past 
memory: p  ! 0.05), problem solving (p  ! 0.03) and judg-
ment (p  ! 0.05). On the affect axis, delusions were sig-
nificantly less prominent in AgD than in AD (p  ! 0.02). 
Again, no differences were found in ADL/behavioral 
symptoms between the AgD and AD patients. 
 Discussion
 To our knowledge, this is the first study to compare 
the clinical features in AgD with those in AD. Thirty 
symptoms commonly encountered in dementia patients 
were retrospectively assessed in autopsy-confirmed 
AgD and AD patients with a novel tool, the RDI. The 
burden of cognitive dysfunction was smaller in AgD 
than in AD in several domains: memory, language, at-
tention, and executive function. These findings do not 
contradict reports  [7] indicating that behavioral symp-
toms are a characteristic feature of AgD. With relatively 
preserved cognitive functions, behavioral symptoms 
may dominate the clinical picture. Compared with AD, 
AgD patients generally presented with ADL/behavioral 
and affective symptoms at a comparable stage in the 
course of the disease except for later appearance of lan-
guage and problem-solving difficulties. Thus, our re-
sults suggest that neuropsychological profiles eventu-
ally help in differentiating between AgD and AD. The 
diagnosis of AgD should be considered when patients 
exhibit deficits in ADL, behavior and affect character-
istic of AD, yet have cognitive functions that are rela-
tively preserved.
 The clinical pattern of AgD in our study is consistent 
with the to pographic distribution of its pathology. AgD 
is a progressive neurodegenerative disorder with an ap-
parently stereotypical temporospatial spreading of path-
ological changes in limbic structures, including the am-
bient gyrus, amygdala, entorhinal cortex and regions of 
the hippocampal formation  [19] . This pattern, as well as 
concomitant AD-type changes found in most AgD cases 
 [4] , might explain the substantial overlap in AgD and AD 
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ADL/behavioral and affective symptomatology. Howev-
er, in contrast to AD, there is only mild neuronal loss in 
limbic structures and, importantly, neocortical involve-
ment in AgD is scarce  [4, 19] , a pattern which may ac-
count for the relative sparing of cognitive functions early 
in the course of AgD. Previous case studies of patients 
with AgD reported behavioral disturbances suggestive of 
frontotemporal dementia (such as inappropriate social 
conduct, egocentric, obsessive-compulsive, disinhibited 
behavior, dietary changes and apathy)  [1, 8] . Some of 
Motor behavior
Disturbing behavior
Hobbies
Social behavior
Appetite
Continence
Sleep
Depression
Disinhibition
Aggression
Compulsion
Anxiety
Delusion
Hallucinations
Mood
Lability
IADL
Concentration
Orientation
Recent memory
Past memory
Attention
Comprehension
Cognition
8 7
T
6 5
Years prior to death (± SEM)
4 3 2 1 0
*
*
Aﬀect
ADL/behavior
Problem solving
Verbal expression
Judgment
Object recognition
Face recognition
Articulation
ADL
AgD patients AD patients
 Fig. 1. Reported symptom onset in patients 
with AgD and AD. IADL = Instrumental 
ADL; T = trend (p = 0.06).  * p  ! 0.05. 
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these reported cases  [8] exhibited marked frontal and/or 
temporal lobe atrophy and widespread neocortical ArG, 
features which are not usually observed in AgD. How-
ever, in the present study, patients displayed neither fron-
totemporal dementia-like symptoms nor neuropatholo-
gy. We therefore suggest that a rarer fron totemporal form 
of AgD may exist alongside the more common limbic 
form of AgD. A number of caveats must be mentioned. 
This study relied on retrospective observations of infor-
mants. Retrospective studies work with ambiguous in-
formation. The sources may not be reliable and the an-
swers could be influenced by the relationship between the 
Hobbies
ADL
Motor behavior
Social behavior
Continence ADL/behavior
Aﬀect
Cognition
*
*
*
*
*
*
*
*
Appetite
Disturbing behavior
Sleep
Depression
Compulsion
Anxiety
Disinhibition
Aggression
Mood
Lability
Hallucinations
IADL
Concentration
Comprehension
Attention
Recent memory
Orientation
Problem solving
Past memory
Verbal expression
Object recognition
Judgment
Face recognition
Articulation
0 1
Symptom load (± SEM)
2 3 4
Delusion
AgD patients AD patients
 Fig. 2. Reported symptom load (symptom 
duration  ! extent) in patients with AgD 
and AD. IADL = Instrumental ADL.  * p  ! 
0.05. 
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informant and the patient. Moreover, recollections of pa-
tients’ histories dating back several years may be inaccu-
rate. Clearly, prospective studies of the clinical-neuro-
pathological characteristics of AgD are required to re-
solve many of these questions.
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